Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.74
+0.29 (2.53%)
Sep 3, 2026, 1:41 PM EDT - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.96 billion as of September 3, 2026. Its market cap has increased by 25.53% in one year.
Market Cap
3.96B
Enterprise Value
4.30B
1-Year Change
25.53%
Ranking
Category
Stock Price
$11.74
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.96B, an increase of 3,337.12%. That is a compound annual growth rate of 49.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 3.96B | 56.58% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 4.24B |
| Legend Biotech | 4.09B |
| Veradermics | 4.07B |
| Relay Therapeutics | 4.05B |
| Viking Therapeutics | 3.93B |
| IDEAYA Biosciences | 3.85B |
| Arcus Biosciences | 3.78B |
| Tango Therapeutics | 3.77B |